{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:41:50Z","timestamp":1788327710836,"version":"build-2803163510"},"reference-count":22,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1136\/bjophthalmol-2014-306364","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:41:34Z","timestamp":1429058494000},"page":"1366-1371","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma"],"prefix":"10.1136","volume":"99","author":[{"given":"Rachel C","family":"Brennan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Qaddoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"Billups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy L","family":"Free","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett G","family":"Haik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodriguez-Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2014-306364-1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archopht.1996.01100140539004","article-title":"Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma","volume":"114","author":"Kingston","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-2","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0161-6420(97)30053-0","article-title":"Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306364-3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2009.12.030","article-title":"Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)","volume":"117","author":"Abramson","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306364-4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archopht.120.12.1653","article-title":"Chemoreduction for unilateral retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ohc.2004.11.002","article-title":"Chemotherapy for retinoblastoma","volume":"18","author":"Chan","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2014-306364-6","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306364-7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.0.CO;2-3","article-title":"Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution","volume":"77","author":"Khelfaoui","year":"1996","journal-title":"Cancer"},{"key":"key-10.1136\/bjophthalmol-2014-306364-8","first-page":"41","article-title":"Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination","volume":"119","author":"Uusitalo","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0161-6420(89)32910-1","article-title":"Optic nerve involvement in retinoblastoma","volume":"96","author":"Magramm","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2014-306364-10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bjo.63.8.560","article-title":"Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases","volume":"63","author":"Stannard","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archopht.120.7.923","article-title":"Postenucleation adjuvant therapy in high-risk retinoblastoma","volume":"120","author":"Honavar","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bjo.2009.177444","article-title":"A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma","volume":"95","author":"Wilson","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pbc.21067","article-title":"Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma","volume":"49","author":"Chantada","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/bjophthalmol-2014-306364-14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/bjo.2003.037044","article-title":"Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?","volume":"88","author":"Chantada","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.2000.18.1.12","article-title":"Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma","volume":"18","author":"Friedman","year":"2000","journal-title":"J Clin Oncol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archopht.117.7.885","article-title":"Thermotherapy for retinoblastoma","volume":"117","author":"Shields","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pbc.20094","article-title":"Episcleral plaque brachytherapy for retinoblastoma","volume":"43","author":"Merchant","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.1136\/bjophthalmol-2014-306364-18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.5858\/2010-0311-OAR2","article-title":"A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country","volume":"135","author":"Suryawanshi","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.1136\/bjophthalmol-2014-306364-19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2010.32.5332","article-title":"Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis","volume":"29","author":"Zhao","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-20","first-page":"164","article-title":"The evaluation and current concept of retinoblastoma therapy","volume":"67","author":"Reese","year":"1963","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"key-10.1136\/bjophthalmol-2014-306364-21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"key-10.1136\/bjophthalmol-2014-306364-22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ophtha.2012.10.044","article-title":"High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes","volume":"120","author":"Kaliki","year":"2013","journal-title":"Ophthalmology"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2014-306364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:49:36Z","timestamp":1601110176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2014-306364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,9,22]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1136\/bjophthalmol-2014-306364"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306364","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}